Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies

نویسندگان

  • T J Key
  • P N Appleby
  • G K Reeves
  • R C Travis
  • L A Brinton
  • K J Helzlsouer
  • J F Dorgan
  • S M Gapstur
  • M M Gaudet
  • R Kaaks
  • E Riboli
  • S Rinaldi
  • J Manjer
  • G Hallmans
  • G G Giles
  • L Le Marchand
  • L N Kolonel
  • B E Henderson
  • S S Tworoger
  • S E Hankinson
  • A Zeleniuch-Jacquotte
  • K Koenig
  • V Krogh
  • S Sieri
  • P Muti
  • R G Ziegler
  • C Schairer
  • B J Fuhrman
  • E Barrett-Connor
  • G A Laughlin
  • E J Grant
  • J Cologne
  • W Ohishi
  • A Hida
  • J A Cauley
  • E O Fourkala
  • U Menon
  • T E Rohan
  • H D Strickler
  • M J Gunter
چکیده

Epidemiological studies have examined breast cancer risk in relation to sex hormone concentrations measured by different methods: "extraction" immunoassays (with prior purification by organic solvent extraction, with or without column chromatography), "direct" immunoassays (no prior extraction or column chromatography), and more recently with mass spectrometry-based assays. We describe the associations of estradiol, estrone and testosterone with both body mass index and breast cancer risk in postmenopausal women according to assay method, using data from a collaborative pooled analysis of 18 prospective studies. In general, hormone concentrations were highest in studies that used direct assays and lowest in studies that used mass spectrometry-based assays. Estradiol and estrone were strongly positively associated with body mass index, regardless of the assay method; testosterone was positively associated with body mass index for direct assays, but less clearly for extraction assays, and there were few data for mass spectrometry assays. The correlations of estradiol with body mass index, estrone and testosterone were lower for direct assays than for extraction and mass spectrometry assays, suggesting that the estimates from the direct assays were less precise. For breast cancer risk, all three hormones were strongly positively associated with risk regardless of assay method (except for testosterone by mass spectrometry where there were few data), with no statistically significant differences in the trends, but differences may emerge as new data accumulate. Future epidemiological and clinical research studies should continue to use the most accurate assays that are feasible within the design characteristics of each study.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies

Epidemiological studies have examined breast cancer risk in relation to sex hormone concentrations measured by different methods: ‘‘extraction’’ immunoassays (with prior purification by organic solvent extraction, with or without column chromatography), ‘‘direct’’ immunoassays (no prior extraction or column chromatography), and more recently with mass spectrometry-based assays. We describe the ...

متن کامل

Relationships between Body Mass Index, Serum Leptin Levels, and 17β-Estradiol in Postmenopausal Women with Breast Cancer: A Case-Control Study

Introduction: There is a close relationship between the incidence of breast cancer and fat intake in different populations. Overweight and obesity during menopause can increase the risk of breast cancer in women. Hormones like estrogen and leptin are factors that affect the growth and proliferation of breast cells. The main purpose of this study was to evaluate the relationships between body ma...

متن کامل

First pregnancy characteristics, postmenopausal breast density, and salivary sex hormone levels in a population at high risk for breast cancer

BACKGROUND It remains unknown if later life breast cancer risk as determined by reproductive history is mediated by postmenopausal breast density and/or sex steroid levels. METHODS Increased breast density is a strong surrogate for future breast cancer risk. A cross-sectional study with a longitudinal follow up for breast health outcomes evaluated women without breast cancer (n = 1,023; 682 =...

متن کامل

Serum Liver proteins and 17β-estradiol in Postmenopausal Women with Breast Cancer

Background: Breast cancer is a hormone-dependent malignancy that is associated with estrogen and progesterone interactions. The liver is the most important organ to be affected by the metastasis of breast cancer, which causes functional impairment. We compared levels of obesity, 17β-estradiol, and secreted proteins in postmenopausal women with breast cancer but without hepatic symptoms to those...

متن کامل

Standardization of steroid hormone assays: why, how, and when?

Lack of standardization of high-quality steroid hormone assays is a major deficiency in epidemiologic studies. In postmenopausal women, reported levels of serum 17beta-estradiol (E(2)) are highly variable and median normal values differ by approximately a 6-fold factor. A particular problem is the use of E(2) assays for prediction of breast cancer risk and osteoporotic fractures, where assay se...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 99  شماره 

صفحات  -

تاریخ انتشار 2015